125 related articles for article (PubMed ID: 5155559)
1. [Study of anti-Au antibodies in polytransfused thalassemic patients].
Moscatelli P; Burlando L; Sciarratta GV
Pathologica; 1971; 63(925):275-9. PubMed ID: 5155559
[No Abstract] [Full Text] [Related]
2. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA
Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791
[No Abstract] [Full Text] [Related]
3. [Incidence of Australia antigen (HB Ag) and its related antibody (HB Ab) in Siciliam thalassemic children treated with multiple transfusions].
Musumeci S; Di Gregorio F; Marino S; Fischer A; Pizzarelli G
Pediatria (Napoli); 1977 Mar; 85(1):21-33. PubMed ID: 876745
[No Abstract] [Full Text] [Related]
4. Prevalence of Au-Ag and Au-Ab in transfused children with thalassaemia in Greece.
Kattamis C; Syriopoulou V; Davri-Karamouzi Y; Demetriou D; Matsaniotis N
Arch Dis Child; 1974 Jun; 49(6):450-3. PubMed ID: 4853764
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis-B virus markers in multi-transfused thalassemic patients.
Mital MK; Vij JC; Talukdar B; Sachdev HP; Saini L
Indian Pediatr; 1988 Feb; 25(2):161-5. PubMed ID: 3246395
[No Abstract] [Full Text] [Related]
6. [Immunologic markers of type B viral hepatitis in patients with homozygote transfusion-dependent beta-thalassemia].
Del Poeta G; Masi M
Recenti Prog Med; 1983 Sep; 74(9):999-1011. PubMed ID: 6658174
[No Abstract] [Full Text] [Related]
7. [Prevalence of hepatitis A antibodies in polytransfused thalassemic patients].
Mangiagli A
Pediatr Med Chir; 1997; 19(6):437-8. PubMed ID: 9595581
[TBL] [Abstract][Full Text] [Related]
8. The genetic relationships of Australia antigen.
London WT
Vox Sang; 1973; 24():Suppl:1-7. PubMed ID: 4124190
[No Abstract] [Full Text] [Related]
9. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand.
Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte antibodies in thalassemic patients.
Sujirachato K; Chiewsilp P; Isarangkura P
Birth Defects Orig Artic Ser; 1988; 23(5B):283-5. PubMed ID: 3390553
[No Abstract] [Full Text] [Related]
12. HLA class I antibodies in thalassemic patients.
Nathalang O; Torcharus K; Chuansumrit A; Punyaprasiddhi P; Sriphaisal T; Tatsumi N
Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):801-4. PubMed ID: 10772568
[TBL] [Abstract][Full Text] [Related]
13. Antibody against hepatitis associated antigen (H.A.A.) in children with thalassemia and the risk of posttransfusion hepatitis.
Pongpipat D; Suvatte V; Ratanawong A
J Med Assoc Thai; 1973 Jun; 56(6):341-6. PubMed ID: 4784773
[No Abstract] [Full Text] [Related]
14. [Importance of Australia antigen determination in patients with multiple transfusions].
Sandu L; Milcov V; Babeş V
Chirurgia (1951); 1973 Dec; 22(12):1123-7. PubMed ID: 4775046
[No Abstract] [Full Text] [Related]
15. Australia antigen (HBsAg) in thallassemia children receiving multiple transfusions.
Mehta KP; Patil HL; Merchant SM; Babar ST; Baxi AJ; Bapat JP
Indian Pediatr; 1977 Jun; 14(6):455-9. PubMed ID: 604273
[No Abstract] [Full Text] [Related]
16. Australia antigen and hepatitis: recent observations on the serum protein polymorphism, infectious agent hypotheses.
London WT; Sutnick AI; Millman I; Coyne V; Blumberg BS; Vierucci A
Can Med Assoc J; 1972 Feb; 106(Spec Issue):Suppl:480-5. PubMed ID: 4552631
[No Abstract] [Full Text] [Related]
17. Antibodies to hepatitis C virus in thalassemia.
Angelucci E
Haematologica; 1994; 79(4):353-5. PubMed ID: 7528705
[TBL] [Abstract][Full Text] [Related]
18. Serum lipids and their modifications after blood transfusion in polytransfused beta-thalassemic patients.
Leonardi S; Colianni R; Fischer A; Curreri R; Di Gregorio F; Pizzarelli G; Musumeci S
Haematologica; 1988; 73(4):269-71. PubMed ID: 3139529
[No Abstract] [Full Text] [Related]
19. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK
Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761
[TBL] [Abstract][Full Text] [Related]
20. [Serum hepatitis from the viewpoint of Au-SH antigen studies].
Wewalka F
Bibl Haematol; 1971; 37():235-42. PubMed ID: 5138909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
